Vetter Starts Operations in Its Center for Visual Inspection and Logistics
Site enlargement enables increased capacity for state-of-the-art quality control and storage
Vetter, a contract development and Manufacturing Organization (CDMO) for development, aseptic filling and final packaging of injectables, has announced that it has begun operations in its expanded Visual Inspection and Logics Center located in Ravensburg. The enlargement, in which the company invested approximately 100 million euros ($107 million), bundles capacity for final product inspection and logistics in one cutting-edge site. By finalizing the second construction stage of the site that was initially put into operation five years ago, the CDMO now offers more than double the capacity for state-of-the-art quality control, cold-storage and room-temperature storage. Given the increasing industry-specific requirements emanating from customer and regulatory side, the company now provides even more efficient and flexible supply chain processes.
The expanded Center, referred to as Ravensburg Vetter West, is located on approximately 50,000 square meters (538,000 square feet) of floor space and offers a 35,000 pallet warehouse capacity for storing pharmaceuticals in refrigeration or room temperature conditions. The capacities for chest freezers, incubation chambers, and constant climate chambers have also been increased, as have the visual inspection capacities of filled units which can be realized in either manual or automatic mode. This allows Vetter to react with greater flexibility to individual market and customer needs. The center also contains a support materials warehouse with corresponding safety installations as well as a new packaging-check laboratory and the company’s central archive. Additionally, the number of office workspaces were increased. By the end of 2017, the CDMO will relinquish its existing Holbeinstrasse site for visual inspection and logistics. Its employees and departments will gradually be relocated to Ravensburg Vetter West, resulting in a working staff of approximately 800 employees.
“The requirements regarding final product inspection as well as transportation and storage of (bio-)pharmaceutical materials are ever-increasing,” said Vetter Managing Director Thomas Otto. “Concentrating our supply chain processes in one site enables bundled resources for even more efficient and highly-secured logistic and quality control procedures.”
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
UC Riverside researcher names lichen after President Barack Obama
Analytik Jena appoints new managing director at Japanese subsidiary
Generation of human brain organoids with the ability to learn - Bioengineered Neuronal Organoids recapitulate important morphological features of the human brain
Stem Cells from Placenta Show Promise for Treating Heart Failure
Amorfix announces leading sensitivity for prion detection in spiked human blood samples
The 7th BioProScale Symposium took place again as in-person event in Berlin - New ways of thinking are required: Scientists from both academia and industry presented and discussed innovative approaches and developments in biotechnology and bioprocess engineering
Emerging gene editing approach seeks broad spectrum crop disease resistance
New Start-up develops aquafarms for macroalgae - AWI and Carbonwave spin-off: Large algae simultaneously bind CO₂ and create raw materials for the chemical industry
Variants in 3 genes account for most dog coat differences - Method for pinpointing gene combinations useful for studies of human disease
Lab-grown canine skin provides a canvas for testing medical treatments - Eliminating the need for animal testing
Data analysis looks at Zika’s introduction to Americas, predicts microcephaly cases
